Northwest Biotherapeutics, Inc.
NWBOW
NWBOW was delisted on the 16th of December, 2016.
2 hedge funds and large institutions have $135K invested in Northwest Biotherapeutics, Inc. in 2013 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Allianz Asset Management
Munich,
Germany
| $135K | +$181K | +90,050 | New |
|
|
U
2
UBS
Zurich,
Switzerland
| – | +$201 | +100 | New |
|
NWBOW Hedge Fund Activity: Q2 2013 in Review
2 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Northwest Biotherapeutics, Inc. (NWBOW) for Q2 2013, worth a combined $135K.
Buyers outnumbered sellers: 2 funds opened new NWBOW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
- 2 institutional investors held Northwest Biotherapeutics, Inc. (NWBOW) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $135K of Northwest Biotherapeutics, Inc. stock for Q2 2013.
- 2 funds opened new Northwest Biotherapeutics, Inc. positions in Q2 2013 and 0 closed out, a net change of +2 holders.
Based on aggregated 13F filings for Q2 2013.